Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9193749
APP PUB NO 20140011988A1
SERIAL NO

13767478

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to compounds for the inhibition of histone deacetylase. More particularly, the invention provides for compounds of formula (I)

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FORUM PHARMACEUTICALS INC225 SECOND AVENUE WALTHAM MA 02451

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Beaulieu, Patrick Laval, CA 34 509
Chantigny, Yves Andre Pincourt, CA 9 159
Chesworth, Richard Boston, US 171 3995
Deziel, Robert Mount-Royal, CA 43 705
Leit, Silvana Kirkland, CA 19 747
Mancuso, John Vaudreuil, CA 20 217
Shapiro, Gideon Gainesville, US 125 2170
Smil, David Montreal, CA 13 351
Tessier, Pierre Hawkesbury, CA 11 437

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 24, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00